doi:10.1016/j.molmed.2017.08.001 4 de Picciotto NE, Gano LB, Johnson LC, et al
Policy The findings support continuing the use of GLP-1 medications in women with metabolic risk factors who are considering pregnancy, says Cara Dolin, MD, a maternal-fetal medicine specialist, and a coauthor of the research, which was presented at the Society of Maternal-Fetal Medicine pregnancy meeting in February 2026
Take it with food to improve absorption and reduce stomach upset
(PubMed) Mason SA, Keske MA, Wadley GD
Safe & Gentle Free from harsh chemicals that damage the skin barrier
It is the reference compound for GLP-1R-specific effects and has the richest published dataset